Agilent Technologies of Santa Clara, Calif., has received US Patent No. 8,221,978, "Normalization probes for comparative genome hybridization arrays." A method of selecting a set of normalization probes for use on a comparative genome hybridization array is provided. It includes: selecting a first region of a genome to be evaluated by comparative genome hybridization to produce data; selecting a second region of the genome for normalization of the data, and selecting from a set of candidate probes a sub-set of normalization probes that detect the second region.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.